Taking biotechnology to the patient: at what cost?
Enlargement of people’s choices is one form of human development. To this extent, biotechnology as a treatment option for certain human ailments such as genetic disorders can be taken as an effort towards human development, as it definitely extends the range of choices available to the public. The issue of ‘taking biotechnology to the patient’ goes beyond mere technology development, which is a supply side activity that may not take into account the demand side requirements such as accessibility and affordability-two important attributes for the success of any intervention technique.
There are currently no refbacks.